Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Congrats to Howhee and Hophee and their elves.

<< Previous

Bullboard Posts

Next >>

Post by bealerton Oct 04, 2022 1:13pm

153 Views

Post# 35004533

Congrats to Howhee and Hophee and their elves.

Congrats for a new year low share price on what was to be the ultimate deal of salvation.

You people at Sirona should ALL give your exhorbitant salaries back to the company, as well as your bonuses because you haven't created a damned thing one can take to the bank.

The story of taking a silk purse and turning it into a sow's ear fits this narative to a tee!

Here we go again, back to the future, and hoping something will crack loose so we can escape.

BeAlert

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario